Explore a selection of our essential drug information below, or:
Identification
- Summary
Agrostis gigantea pollen is an extract from Agrostis gigantea pollen used in allergy testing.
- Generic Name
- Agrostis gigantea pollen
- DrugBank Accession Number
- DB10403
- Background
Agrostis gigantea pollen is the pollen of the Agrostis gigantea plant. Agrostis gigantea pollen is mainly used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Allergenic Extract, Redtop Grass
- Standardized redtop grass pollen
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAcebutolol The risk of a hypersensitivity reaction to Agrostis gigantea pollen is increased when it is combined with Acebutolol. Atenolol The risk of a hypersensitivity reaction to Agrostis gigantea pollen is increased when it is combined with Atenolol. Benazepril The risk or severity of adverse effects can be increased when Benazepril is combined with Agrostis gigantea pollen. Betaxolol The risk of a hypersensitivity reaction to Agrostis gigantea pollen is increased when it is combined with Betaxolol. Bisoprolol The risk of a hypersensitivity reaction to Agrostis gigantea pollen is increased when it is combined with Bisoprolol. - Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Allergenic Extract - Standardized Grass Pollen - Red Top Liquid 100000 unit / mL Intradermal; Subcutaneous Greer Laboratories, Inc. 2000-10-30 Not applicable Canada 
Allergenic Extract - Standardized Grass Pollen - Red Top Liquid 10000 unit / mL Intradermal; Subcutaneous Greer Laboratories, Inc. Not applicable Not applicable Canada Allergenic Extract - Standardized Redtop Grass Pollen Liquid 100000 unit / mL Intradermal; Percutaneous; Subcutaneous ALK-Abello, Inc. 2009-07-30 Not applicable Canada Redtop Grass, Standardized Solution 10000 [BAU]/1mL Percutaneous ALK-Abello, Inc. 1997-12-18 2019-10-17 US 
Redtop Grass, Standardized Injection, solution 100000 [BAU]/1mL Subcutaneous ALK-Abello, Inc. 1997-12-18 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image 5 Grass Mix Agrostis gigantea pollen (5000 [PNU]/1mL) + Anthoxanthum odoratum pollen (5000 [PNU]/1mL) + Dactylis glomerata pollen (5000 [PNU]/1mL) + Phleum pratense pollen (5000 [PNU]/1mL) + Poa pratensis pollen (5000 [PNU]/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1975-01-15 2023-05-25 US 5 Grass Mix Agrostis gigantea pollen (100 [PNU]/1mL) + Anthoxanthum odoratum pollen (100 [PNU]/1mL) + Dactylis glomerata pollen (100 [PNU]/1mL) + Phleum pratense pollen (100 [PNU]/1mL) + Poa pratensis pollen (100 [PNU]/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1975-01-15 2023-05-24 US 5 Grass Mix Agrostis gigantea pollen (1000 [PNU]/1mL) + Anthoxanthum odoratum pollen (1000 [PNU]/1mL) + Dactylis glomerata pollen (1000 [PNU]/1mL) + Phleum pratense pollen (1000 [PNU]/1mL) + Poa pratensis pollen (1000 [PNU]/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1975-01-15 2023-05-25 US 5 Grass Mix Agrostis gigantea pollen (20000 [PNU]/1mL) + Anthoxanthum odoratum (20000 [PNU]/1mL) + Dactylis glomerata pollen (20000 [PNU]/1mL) + Phleum pratense pollen (20000 [PNU]/1mL) + Poa pratensis pollen (20000 [PNU]/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1975-01-15 2023-05-25 US 5 Grass Mix Agrostis gigantea pollen (10000 [PNU]/1mL) + Anthoxanthum odoratum pollen (10000 [PNU]/1mL) + Dactylis glomerata pollen (10000 [PNU]/1mL) + Phleum pratense pollen (10000 [PNU]/1mL) + Poa pratensis pollen (10000 [PNU]/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1975-01-15 2023-05-25 US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- HU8V6E7HOA
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data3 Completed Treatment Allergic Reaction 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution Intradermal; Percutaneous; Subcutaneous Injection, solution Subcutaneous Liquid Intradermal; Percutaneous; Subcutaneous Liquid Intradermal; Subcutaneous 10000 unit / mL Liquid Intradermal; Subcutaneous 100000 unit / mL Liquid Intradermal; Percutaneous; Subcutaneous 100000 unit / mL Liquid Subcutaneous Solution Intradermal; Subcutaneous Injection, solution Percutaneous Injection, solution Subcutaneous 10000 [BAU]/1mL Injection, solution Subcutaneous 100000 [BAU]/1mL Solution Percutaneous 10000 [BAU]/1mL Solution Percutaneous 100000 [BAU]/1mL Liquid Intradermal 100 unit / mL Liquid Intradermal 1000 unit / mL Solution Percutaneous; Subcutaneous 10000 unit / mL Solution Percutaneous; Subcutaneous 100000 unit / mL Injection, solution Intradermal Injection, solution Percutaneous; Subcutaneous Injection, solution Intradermal 100 [BAU]/1mL Injection, solution Intradermal 1000 [BAU]/1mL Injection, solution Percutaneous; Subcutaneous 10000 [BAU]/1mL Injection Cutaneous; Intradermal; Subcutaneous 100000 [BAU]/1mL Injection, solution Intradermal; Subcutaneous 10000 [BAU]/1mL Injection, solution Intradermal; Subcutaneous 100000 [BAU]/1mL Injection, solution Percutaneous; Subcutaneous 100000 [BAU]/1mL Solution Intradermal; Percutaneous; Subcutaneous 10000 [BAU]/1mL Solution Intradermal; Percutaneous; Subcutaneous 100000 [BAU]/1mL Injection, solution Intradermal; Subcutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:03 / Updated at October 30, 2024 19:34